This is the story of a mother-of-four called Baby from Haryana in Northern India. She was suffering from chronic kidney disease but could only afford life-saving dialysis once a week – she needed to go three times. Shortly after filming ended we learned she stopped......
When I was eight, my parents took me and my siblings from our home in Morocco to live in England. They didn’t do it for the weather. They did it because they understood the United Kingdom promised those within its borders basic dignities: the right......
This post was originally published on LinkedIn by Parisa Glass, Director of Innovation and Enterprise, and Professor Vlado Perkovic and is reproduced here with her kind permission. Healthcare is usually a slow-moving industry, and mostly for good reason. In medicine, patient safety and evidence-based practice......
The AustralaSian COVID-19 Trial (ASCOT) has been expanded into India, with the first patients recruited to the first two sites, Christian Medical College and Hospital Ludhiana in Punjab and Sterling Multispecialty Hospital in Pune, Maharashtra. ASCOT aims to discover which existing treatments are most effective in......
A new Australian product designed to make kidney dialysis more broadly available at low cost has won first prize in a global health innovations competition. The Affordable Dialysis System, developed by Sydney-based Ellen Medical, beat more than 500 entries from 22 countries to score top......
463 million people are living with diabetes, which is expected to rise to 578 million by 2030. This year, the focus of World Diabetes Day is raising awareness about the critical need for more nurses to prevent and treat diabetes, a chronic condition that if......
When clinical trials become a normal part of care options for patients with unmet needs, both researchers and patients will reap exponential rewards. “Where are the patients?” Clinical trials hinge on recruitment, and enrollment issues are a perpetual challenge. Research estimates that, on average, around......
The video brings together some of George Institute’s experts and partners around the world to consider the importance and impact of COVID-19 on NCD prevention and management in different contexts, and the key research questions emerging as a consequence. Watch the video...
An innovative study to assess whether a commonly used cholesterol lowering medication can prevent brain complications from COVID-19 has received over $2.3m from the Government’s Medical Research Future Fund. The study, a collaboration between The George Institute for Global Health, the University of New South......
Authored by Professor David Peiris and Professor Stephen Jan In this week that we mark World Health Day, the focus on world health is unprecedented. As a research organisation, the obvious question to ask is where the research community should be best focusing our efforts.......
Differences in how blood pressure affects the risk of dementia in men and women may provide clues to help slow the rapid growth of the disease, according to new research published today. In a study of just over half a million people, George Institute researchers......
A new Australian product designed to make kidney dialysis more broadly available at low cost has won first prize in a global health innovations competition. The Affordable Dialysis System, developed by Sydney-based Ellen Medical, beat more than 500 entries from 43 countries to score top......
London, UK, 12 July 2021 – George Medicines, a late-stage drug development company focused on providing innovative and accessible medicines for the world’s leading causes of death, today announces the appointment of Dr Charmaine Gittleson to the Board as Independent Non-Executive Director. Dr Gittleson has......
Mr König joins to lead late-stage drug development company developing proprietary fixed dose combination therapies for non-communicable diseases. US FDA grants IND authorization to commence Phase III trials with triple combination candidate for the treatment of hypertension. Chief Business Officer, Karl Roberts, appointed to new......
Novel proprietary triple low-dose combination pill has been shown to outperform traditional blood pressure treatments without additional side effects in earlier clinical research. Lead candidate in Company’s pipeline of proprietary fixed-dose combination therapies targeting high unmet need in large patient populations suffering from non-communicable diseases......
The World Innovation Summit for Health (WISH) announced the grand prize winners of its two latest Innovation Award competitions during the closing ceremony on Thursday. WISH CEO Sultana Afdhal presented the awards for the WISH Innovation Spark Competition to SOSO Care and the WISH Innovation......
Around half a billion people worldwide have diabetes and up to 40% will go onto develop kidney disease. The global cost of treating diabetes is estimated at almost US$830 billion per year. The lack of access to costly dialysis treatment for kidney failure kills several million......
George Clinical is uniquely placed to meet the increasingly complex and specialized demands of modern oncology research, and as such demonstrating product value in terms of clinical effectiveness, specialized cohorts and tolerability. Read full article...
Dr. Adrian Liew, a nephrologist and scientific leader with George Clinical, was the recipient of the 2020 International Society for Peritoneal Dialysis Congress John Maher Award, honoring young individuals who have contributed substantially to the field of peritoneal dialysis (PD). Maher was a great contributor......
“Extraordinary achievements under unprecedented conditions,” is how Chief Medical Officer Maria Ali describes the reality of a George Clinical team drawing on proven working models, established global relationships and an unflinching dedication to implement a clinical trial in a matter of weeks during a global......
The George Institute for Global Health is delighted to announce the launch of The Scan, a new podcast exploring the latest research, emerging evidence, and progress towards improving health outcomes in non-communicable diseases and injury around the world. Each episode of The Scan will deep dive into a......
Check The George Institute Global E-Newsletter...
Independent health research organisation The George Institute for Global Health has raised $53 million to help it commercialise therapies to tackle chronic diseases such as heart disease and diabetes. Read full article at Financial review...
Affordable dialysis worldwide: Q+A with John Knight of Ellen Medical Devices about the world’s first low-cost dialysis system. Professor John Knight, a children’s kidney specialist, is the Managing Director of Ellen Medical Devices and a senior researcher at The George Institute for Global Health.......
This post was originally published on LinkedIn by Dr Parisa Glass, Director of Innovation and Enterprise, and is reproduced here with her kind permission. We’ve all heard the statistic that 80% of new businesses fail. But it’s less well known why. The simple truth is,......
The World Innovation Summit for Health (WISH) announced the grand prize winners of its two latest Innovation Award competitions during the closing ceremony of WISH 2020 on Thursday. WISH CEO Sultana Afdhal presented the awards for the WISH Innovation Spark Competition to SOSO Care and......
The World Innovation Summit for Health (WISH) announced the grand prize winners of its two latest Innovation Award competitions during the closing ceremony of WISH 2020. WISH CEO Sultana Afdhal presented the awards for the WISH Innovation Spark Competition to SOSO Care and the WISH......